AOD9604 is a modified version of fragment 176-191, which is itself a smaller, modified piece of human growth hormone (HGH)
RGD peptide conjugation results in enhanced antitumor activity of PD0325901 against glioblastoma by both tumor-targeting delivery and combination therapy
As well as telling the pancreas to make more insulin, which helps convert food into energy, the GLP-1 hormone feeds back to the brain and makes users feel full
A novel 3-phenylglutaric acid derivative (84B10) alleviates cisplatin-induced acute kidney injury by inhibiting mitochondrial oxidative stress-mediated ferroptosis
Marketing glutathione for disease treatment, skin whitening, or detoxification without FDA approval violates federal lawthe molecule is legal, but therapeutic claims trigger enforcement
Evidence from studies of brand-name GLP-1 medications suggests that weight regain is common after discontinuation, particularly without sustained lifestyle modifications